Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2013 (2013), Article ID 892054, 5 pages
http://dx.doi.org/10.1155/2013/892054
Case Report

HIV Infection and Acute Stroke: A Case Report and a Review of the Literature

Department of Internal Medicine, Lincoln Medical and Mental Health Center, 234 E 149th Steet, Bronx, NY 10451, USA

Received 8 June 2013; Accepted 1 August 2013

Academic Editor: Ingo W. Husstedt

Copyright © 2013 Hussein Assallum et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Ovbiagele and A. Nath, “Increasing incidence of ischemic stroke in patients with HIV infection,” Neurology, vol. 76, no. 5, pp. 444–450, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Mocroft, B. Ledergerber, C. Katlama et al., “Decline in the AIDS and death rates in the EuroSIDA study: an observational study,” The Lancet, vol. 362, no. 9377, pp. 22–29, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Mary-Krause, L. Cotte, A. Simon, M. Partisani, and D. Costagliola, “Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men,” AIDS, vol. 17, no. 17, pp. 2479–2486, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. B. ILongo-Mbenza, M. Longokolo Mashi, M. Lelo Tshikwela et al., “Relationship between younger age, autoimmunity, cardiometabolic risk, oxidative stress, HAART, and ischemic stroke in Africans with HIV/AIDS,” ISRN Cardiology, vol. 2011, Article ID 897908, 5 pages, 2011. View at Publisher · View at Google Scholar
  5. F. C. Chow, S. Regan, S. Feske et al., “Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system,” Journal of Acquired Immune Deficiency Syndromes, vol. 60, no. 4, pp. 351–358, 2012. View at Publisher · View at Google Scholar
  6. M. J. Vinikoor, S. Napravnik, M. Floris-Moore et al., “Incidence and clinical features of cerebrovascular disease among HIV-infected adults in the Southeastern United States,” AIDS Research and Human Retroviruses, vol. 29, no. 7, pp. 1068–1074, 2013. View at Publisher · View at Google Scholar
  7. S. B. Porter and M. A. Sande, “Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome,” The New England Journal of Medicine, vol. 327, no. 23, pp. 1643–1648, 1992. View at Google Scholar · View at Scopus
  8. S. Lachaud, L. Suissa, and M. H. Mahagne, “Stroke, HIV and meningovascular syphilis: study of three cases,” Revue Neurologique, vol. 166, no. 1, pp. 76–82, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Grunfeld, M. Pang, W. Doerrler et al., “Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 74, no. 5, pp. 1045–1052, 1992. View at Publisher · View at Google Scholar · View at Scopus
  10. S. A. Riddler, E. Smit, S. R. Cole et al., “Impact of HIV infection and HAART on serum lipids in men,” Journal of the American Medical Association, vol. 289, no. 22, pp. 2978–2982, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. S. N. Pujari, A. Dravid, E. Naik et al., “Lipodystrophy and dyslipidemia among patients taking first-line, World Health Organization-recommended highly active antiretroviral therapy regimens in Western India,” Journal of Acquired Immune Deficiency Syndromes, vol. 39, no. 2, pp. 199–202, 2005. View at Google Scholar · View at Scopus
  12. L. H. Kuller, R. Tracy, W. Belloso et al., “Inflammatory and coagulation biomarkers and mortality in patients with HIV infection,” PLoS Medicine, vol. 5, no. 10, article e203, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Schillaci, G. V. L. de Socio, M. Pirro et al., “Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 11, pp. 2381–2385, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. F. J. Torriani, L. Komarow, R. A. Parker et al., “Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy. The ACTG (AIDS Clinical Trials Group) Study 5152s,” Journal of the American College of Cardiology, vol. 52, no. 7, pp. 569–576, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Murphy and D. Costagliola, “Increased cardiovascular risk in HIV infection: drugs, virus and immunity,” AIDS, vol. 22, no. 13, pp. 1625–1627, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. K. de Gaetano Donati, R. Rabagliati, M. Tumbarello et al., “Increased soluble markers of endothelial dysfunction in HIV-positive patients under highly active antiretroviral therapy,” AIDS, vol. 17, no. 5, pp. 765–768, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. S. S. Shankar, M. P. Dubé, J. C. Gorski, J. E. Klaunig, and H. O. Steinberg, “Indinavir impairs endothelial function in healthy HIV-negative men,” American Heart Journal, vol. 150, no. 5, pp. 933.e1–933.e7, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. F. J. Palella Jr., S. J. Gange, L. Benning et al., “Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study,” AIDS, vol. 24, no. 11, pp. 1657–1665, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. E. C. Seaberg, A. Muñoz, M. Lu et al., “Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003,” AIDS, vol. 19, no. 9, pp. 953–960, 2005. View at Google Scholar · View at Scopus
  20. T. T. Brown, S. R. Cole, X. Li et al., “Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study,” Archives of Internal Medicine, vol. 165, no. 10, pp. 1179–1184, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. V. A. Triant, J. B. Meigs, and S. K. Grinspoon, “Association of C-reactive protein and HIV infection with acute myocardial infarction,” Journal of Acquired Immune Deficiency Syndromes, vol. 51, no. 3, pp. 268–273, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. P. C. Tien, A. I. Choi, A. R. Zolopa et al., “Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort,” Journal of Acquired Immune Deficiency Syndromes, vol. 55, no. 3, pp. 316–322, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. A. D. Blann, M. Seigneur, J. Constans, J. L. Pellegrin, and C. Conri, “Soluble P-selectin, thrombocytopenia and von Willebrand factor in HIV infected patients,” Thrombosis and Haemostasis, vol. 77, no. 6, pp. 1221–1222, 1997. View at Google Scholar · View at Scopus
  24. M. Karmochkine, A. Ankri, V. Calvez, M. Bonmarchant, A. Coutellier, and S. Herson, “Plasma hypercoagulability is correlated to plasma HIV load,” Thrombosis and Haemostasis, vol. 80, no. 1, pp. 208–209, 1998. View at Google Scholar · View at Scopus
  25. M. Erbe, V. Rickerts, R. M. Bauersachs, and E. Lindhoff-Last, “Acquired protein C and protein S deficiency in HIV-infected patients,” Clinical and Applied Thrombosis/Hemostasis, vol. 9, no. 4, pp. 325–331, 2003. View at Google Scholar · View at Scopus